Apixaban formulations

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Holdings Ireland;Pfizer Inc.

发明人:

PATEL, Jatin,FROST, Charles,JIA, Jingpin,VEMA-VARAPU, Chandra

申请号：

ES17175788

公开号：

ES2758031T3

申请日:

2011.02.24

申请国别(地区):

ES

年份:

2020

代理人:

摘要：

Compositions comprising crystalline apixaban particles having a D 90 equal to or less than 89 µm, and a pharmaceutically acceptable carrier, are substantially bioequivalent and can be used to for the treatment and/or prophylaxis of thromboembolic disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/